No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study

Adriaanse, Marcel C.; Snoek, Frank J.; Dekker, Joost; Spijkerman, Annemieke M.W.; Nijpels, Giel; Twisk, J.W.R.; Ploeg, Henk M. van der; Heine, Robert J.

doi:10.1111/j.1464-5491.2004.01276.x

Cited by 38 publications

(27 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other outcome measures of screening procedures are psychosocial well-being and cardiovascular morbidity and mortality. In a targeted screening programme, the diagnosis of type 2 diabetes had no substantial adverse or positive effect on psychological well-being and perceived health status [10]. In summary, in contrast to macrovascular complications, some microvascular events, such as background retinopathy, could theoretically be prevented by earlier diagnosis and better glycaemic control [11].…”

Section: Introductionmentioning

confidence: 99%

Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS)

Ponto

Koenig²,

Pető

et al. 2016

Diabetologia

View full text Add to dashboard Cite

Aims/hypothesis Individuals with type 2 diabetes mellitus may experience an asymptomatic period of hyperglycaemia, and complications may already be present at the time of diagnosis. We aimed to determine the prevalence of diabetic retinopathy in patients with newly diagnosed (screeningdetected) type 2 diabetes. Methods The Gutenberg Health Study is a population-based study with 15,010 participants aged between 35 and 74 years. We determined the weighted prevalence of diabetic retinopathy by assessing fundus photographs. Screeningdetected type 2 diabetes was defined as an HbA 1c concentration of 6.5% (47.5 mmol/mol) or more, no medical diagnosis of diabetes and no intake of insulin or oral glucoselowering agents. Results Of 14,948 participants, 1377 (9.2%) had diabetes mellitus. Of these, 347 (25.2%) had newly diagnosed type 2 diabetes detected by the screening. Overall, the weighted prevalence of screening-detected type 2 diabetes was 2.1%. Fundus photos were evaluable for 285 (82.1%) participants with newly diagnosed diabetes. The weighted prevalence of diabetic retinopathy in screening-detected type 2 diabetes was 13.0%; 12% of participants had a mild non-proliferative diabetic retinopathy and 0.6% had a moderate nonproliferative diabetic retinopathy. Diabetic retinopathy was proliferative in 0.3%. No cases of severe non-proliferative diabetic retinopathy or diabetic maculopathy were found. Thirty (14.9%) of 202 and six (7.2%) of 83 individuals with and without concomitant arterial hypertension, respectively, had diabetic retinopathy (OR 2.54, 95% CI 1.06, 7.14). Visual acuity did not differ between individuals with and without diabetic retinopathy . Conclusions/interpretation In this large European study, the prevalence of diabetic retinopathy in screening-detected type 2 diabetes was 13%. Only a very small proportion of participants with detected diabetic retinopathy needed treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS)

Ponto

Koenig²,

Pető

et al. 2016

Diabetologia

View full text Add to dashboard Cite

show abstract

“…Baseline and 1-year SF-36 scores in the Hoorn study did not differ substantially, except for the dimension 'role emotional'. 25 In the US, HRQoL scores at baseline and after 1 year were similar for persons with and without diabetes found at screening, and remained practically unaltered over the year after screening. 26 SF-36 scores between both treatment groups at the end of the study were not different.…”

Section: Routine Carementioning

confidence: 91%

Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study

Janssen

Gorter²,

Stolk³

et al. 2009

Br J Gen Pract

View full text Add to dashboard Cite

“…[21][22][23] In the case of screening for type 2 diabetes, there is evidence of limited psychological impact on patients, [24][25][26] but less is known about the acceptability of specific screening strategies.…”

Section: Resultsmentioning

confidence: 99%

Influences on the uptake of diabetes screening: a qualitative study in primary care

Eborall¹,

Stone²,

Aujla³

et al. 2012

Br J Gen Pract

View full text Add to dashboard Cite

BackgroundTo address the increasing global prevalence of type 2 diabetes healthcare organisations have been contemplating different screening and intervention strategies. Patient acceptability is a key criterion of a screening programme. AimTo explore the perspectives of those invited to attend the MY-WAIST screening study for type 2 diabetes, particularly explanations for attending or not, and views on the specific screening strategy. Design and settingQualitative study with patients from 11 general practices (Leicestershire, UK). MethodSemi-structured interviews were conducted with 24 individuals (40-69 years) invited to attend the MY-WAIST screening study, comprising 13 who attended and 11 who did not attend the screening. Additional data included reply slips from 73 individuals who declined the offer of screening. Analysis was informed by the constant comparative method. ResultsTwo categories of influence on the decision about attending screening emerged. 1) Beliefs about type 2 diabetes candidacy and severity: perceived susceptibility to type 2 diabetes was more common amongs those who had attended; lack of perceived severity of type 2 diabetes was more common amongs those who did not attend. 2) Practical aspects about the screening strategy: the lengthy, early morning screening appointments were a barrier to uptake; screening attendees found the procedure largely acceptable. Prescreening waist self-measurement was more memorable than the remainder of the riskscore calculation; neither impacted on uptake. ConclusionThe barriers to screening uptake highlighted contribute to current debates about different screening and diagnostic tests for type 2 diabetes and future risk of type 2 diabetes. The findings are useful for those contemplating implementation of screening programmes for identifying type 2 diabetes and pre-diabetes.

show abstract

No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study

Abstract: The diagnosis of Type 2 diabetes has no substantial adverse or positive effect on psychological well-being and perceived health status, shortly, and 6 and 12 months after the diagnosis.

Cited by 38 publications

References 23 publications

Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS)

Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS)

Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study

Influences on the uptake of diabetes screening: a qualitative study in primary care

Contact Info

Product

Resources

About